NT-proBNP in ICU Postoperative/Posttraumatic Patients With Shock
NICUPS
NT-proBNP in Postoperative/Posttraumatic Critically Ill Patients With Severe SIRS/Sepsis and Shock
1 other identifier
observational
51
1 country
1
Brief Summary
The purpose of this study is to determine the course of NT-proBNP plasma concentrations in the context of confounding parameters in postoperative/posttraumatic critically ill patients with severe SIRS/sepsis and shock.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2008
CompletedFirst Submitted
Initial submission to the registry
August 14, 2008
CompletedFirst Posted
Study publicly available on registry
August 18, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedResults Posted
Study results publicly available
January 20, 2017
CompletedJanuary 1, 2025
December 1, 2024
4 years
August 14, 2008
December 2, 2015
December 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pattern of NT-proBNP, Biomarkers and Surface Markers on Leukocytes
maximal NT-proBNP concentrations in critically ill surgical patients admitted from 01 July 2008 to 31 Dec 2008 in the ICU revealingnonseptic and septic shock
01 July 2008 to 31 Dec 2008
Study Arms (2)
Patients non-septic shock
Postoperative/posttraumatic critically ill patients with non-septic shock
Patients septic shock
Postoperative/posttraumatic critically ill patients with septic shock
Eligibility Criteria
Postoperative/posttraumatic critically ill patients admitted to the intensive care unit
You may qualify if:
- Critically ill, postoperative/posttraumatic patients with severe systemic inflammatory response syndrome (SIRS) or severe sepsis
You may not qualify if:
- Life expectancy \< 24 hours
- Participation in other trials
- Known or suspected pregnancy
- Contraindications for transesophageal echocardiography (TEE): severe disease of the esophagus (hernia, strictures, esophageal resection, severe bleeding disorders)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinic of Anesthesiology
Ulm, 89070, Germany
Related Publications (2)
Weiss M, Huber M, Nass M, Huber-Lang M, Koenig W, Schneider M. NT-proBNP and HMGB1 in surgical critically ill patients with hypovolemic or septic shock.Infection Suppl. II September 2011; 39: S116-117 5th International Congress of the German Sepsis Society, Weimar Sepsis Update Bridging The Gap, Weimar, 07. - 10.09.2011.
RESULTWeiss M, Huber M, Nass M, Huber-Lang M, Koenig W, Schneider M. NT-proBNP serum concentrations in surgical critically ill patients with non-septic and septic shock. INNOVATIVE JOURNAL OF MEDICAL AND HEALTH SCIENCE 3 (4): 177-184, 2013.
RESULT
Biospecimen
Whole blood, serum, white blood cells
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Myocardial depression has not been verified in our patients by a low cardiac index or by echocardiography
Results Point of Contact
- Title
- Prof. Dr. Manfred Weiss
- Organization
- University
Study Officials
- PRINCIPAL INVESTIGATOR
Manfred Weiss, MD, MBA
Clinic of Anesthesiology, University Hospital Medical School, Steinhoevelstrasse 9, 89070 Ulm, Germany
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, MD, MBA
Study Record Dates
First Submitted
August 14, 2008
First Posted
August 18, 2008
Study Start
August 1, 2008
Primary Completion
August 1, 2012
Study Completion
December 1, 2012
Last Updated
January 1, 2025
Results First Posted
January 20, 2017
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share